HeartSciences Inc.

HeartSciences Inc.

NNASDAQ:HSCS
2.08
USD
-0.04
(-2.12%)
-3.21EPS
8.51MMarket Cap
Dec 10Next Earn

Total Valuation

USD

As of July 31, 2026, HeartSciences Inc. carries a market capitalization of 8.51M, placing it among publicly traded companies globally. Its enterprise value stands at 12.49M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap8.51M
Enterprise Value12.49M

Important Dates

HeartSciences Inc.'s next confirmed earnings release is scheduled for December 10, 2026.

Earnings Date12/10/2026

Share Statistics

As of July 31, 2026, HeartSciences Inc. has 3.90M shares outstanding.

Shares Outstanding3.90M

Valuation Ratios

These figures are as of July 31, 2026. The price-to-sales ratio is 1,543.71, and the price-to-book ratio stands at -4.19.

PS Ratio1,543.71
PB Ratio-4.19
P/TBV Ratio-1.82
P/FCF Ratio-1.02
P/OCF Ratio-1.03

Enterprise Valuation

These figures are as of July 31, 2026. The EV/Sales ratio of 2,763.51 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 12.49M versus a market cap of 8.51M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2,763.51

Financial Position

As of July 31, 2026, HeartSciences Inc. maintains a current ratio of 0.14, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -196.96, indicating conservative leverage, while an interest coverage ratio of -11.61 demonstrates limited ability to service its debt obligations.

Current Ratio0.14
Quick Ratio0.01
Debt / Equity-196.96
Debt / EBITDA-0.43
Interest Coverage-11.61

Financial Efficiency

USD

These figures cover the twelve months ended July 31, 2026. Return on assets (ROA) is negative at -201.67, reflecting losses generated across the asset base. The company generates approximately 311.66 in revenue per employee across its workforce of 14.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.00 indicates how many times HeartSciences Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-201.67
Revenue Per Employee311.66
Employee Count14.50

Stock Price Statistics

USD

As of the close on November 16, 2026, HeartSciences Inc.'s stock has declined approximately 32.25% over the past 52 weeks. The 50-day moving average sits at 3.49, while the 200-day moving average is 2.67.

52-Week Price Change-32.25%
50-Day Moving Average3.49
200-Day Moving Average2.67

Income Statement

USD

Over the twelve months ended July 31, 2026, HeartSciences Inc. generated 4,519.00 in revenue and converted that into -10.26M in net income, yielding earnings per share of -3.21. EBITDA reached -9.34M, while operating income came in at -9.48M.

Revenue4,519.00
Gross Profit2,751.00
Operating Income-9.48M
Pretax Income-10.26M
Net Income-10.26M
EBITDA-9.34M
EBIT-9.48M
Earnings Per Share (EPS)-3.21

Balance Sheet

USD

As of July 31, 2026, HeartSciences Inc. holds 29,906.00 in cash and equivalents against 4.00M in total debt, resulting in a net debt position of 3.69M. Total book value stands at -2.03M, with working capital of -4.82M providing operational flexibility.

Cash & Cash Equivalents29,906.00
Total Debt4.00M
Net Debt3.69M
Equity (Book Value)-2.03M
Book Value Per Share-0.52
Working Capital-4.82M

Cash Flow

USD

HeartSciences Inc. produced -6.79M in operating cash flow over the twelve months ended July 31, 2026. After subtracting -36,217.00 in capital expenditures, free cash flow totaled -6.83M - equivalent to -2.13 per share.

Operating Cash Flow-6.79M
Capital Expenditures-36,217.00
Free Cash Flow-6.83M
FCF Per Share-2.13

Margins

Over the twelve months ended July 31, 2026, HeartSciences Inc. posted a gross margin of 60.88, reflecting its pricing power and cost economics. The operating margin of -209,733.08 and net profit margin of -227,024.23 provide insight into operational efficiency.

Gross Margin60.88
Operating Margin-209,733.08
Pretax Margin-227,024.23
Profit Margin-227,024.23
EBITDA Margin-206,763.33

Dividends & Yields

These figures cover the twelve months ended July 31, 2026. Free cash flow yield is negative at -97.88: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -51.14, meaning HeartSciences Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-51.14
FCF Yield-97.88

Stock Splits

HeartSciences Inc.'s most recent stock split took place on May 17, 2024 with a 100:1 split ratio.

Last Split Date5/17/2024
Split Ratio100:1

Scores

As of July 31, 2026, HeartSciences Inc. has an Altman Z-Score of -147.44, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-147.44